Clinical Trial

68Ga-JH12 PET/CT: Dosimetry and Biodistribution Study

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated November 14, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
68Ga-JH12 is a novel radiotracer targeting C-X-C motif chemokine receptor 4 (CXCR4). In this study, we observed the safety, biodistribution, and radiation dosimetry of 68Ga-JH12 in patients with different types of cancer.
Trial Details
NCT Number NCT06688188
Lead Sponsor First Affiliated Hospital of Fujian Medical University
Conditions Malignant Neoplasm
Enrollment 5 participants
Start Date 2024-11-01
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-14